Medical Technology - Central Africa

Central Africa

In 2024, the projected revenue in the Medical Technology market market in Central Africa is expected to reach US$384.20m.
The largest market within this industry is Medical Devices, with a projected market volume of US$322.20m in the same year.
Looking ahead, the revenue is anticipated to exhibit a compound annual growth rate (CAGR 2024-2029) of 5.48%, resulting in a market volume of US$501.70m by 2029.
When compared globally, it is noteworthy that the United States is expected to generate the highest revenue, reaching US$211.10bn in 2024.
This demonstrates the significant market presence of the United States in the Medical Technology market industry.
Central Africa is experiencing a growing demand for medical technology as the region aims to improve healthcare infrastructure.

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in Central Africa is experiencing significant development and growth. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory. Customer preferences in Central Africa are shifting towards more advanced and innovative medical technologies. Patients and healthcare providers alike are increasingly seeking out state-of-the-art equipment and devices to improve the quality of healthcare services. This preference for advanced medical technology is driven by the desire for accurate diagnoses, efficient treatment options, and improved patient outcomes. As a result, there is a growing demand for medical devices such as imaging systems, diagnostic tools, and surgical equipment. Trends in the market reflect the increasing adoption of medical technology in Central Africa. The region is witnessing a rise in the number of healthcare facilities and hospitals that are equipped with modern medical devices. This trend is driven by the need to upgrade existing healthcare infrastructure and provide better healthcare services to the growing population. Additionally, there is a growing trend towards telemedicine and remote healthcare services, which require the use of advanced medical technology for accurate diagnosis and treatment. Local special circumstances in Central Africa also contribute to the development of the Medical Technology market. The region faces several healthcare challenges, including a lack of access to quality healthcare services in remote areas, limited healthcare infrastructure, and a shortage of healthcare professionals. To address these challenges, governments and healthcare organizations in Central Africa are investing in medical technology to bridge the gap in healthcare delivery. This includes initiatives to improve telemedicine services, increase the availability of medical equipment, and enhance healthcare training programs. Underlying macroeconomic factors further support the growth of the Medical Technology market in Central Africa. The region is experiencing economic growth, which has led to increased healthcare spending. Governments in Central Africa are prioritizing healthcare investments to improve the overall health and well-being of their populations. Additionally, international collaborations and partnerships are driving the transfer of medical technology to the region, further fueling market growth. In conclusion, the Medical Technology market in Central Africa is developing rapidly due to customer preferences for advanced medical devices, trends in the market towards modern healthcare infrastructure, local special circumstances that necessitate the adoption of medical technology, and underlying macroeconomic factors that support healthcare investments. This growth is expected to continue as Central Africa strives to improve healthcare access and quality for its population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.